Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3863_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •Contributors
- •References
- •Introduction
- •History
- •Prevalence
- •Interfering Medications
- •Lab Interpretation
- •Radiological Diagnosis
- •Introduction
- •Etiology
- •Epidemiology
- •Parathyroid Gland Anatomy
- •Clinical Evaluation
- •Historical Presentations
- •Normocalcemic Primary Hyperparathyroidism
- •Laboratory Evaluation
- •Initial Laboratory Testing
- •Calcium
- •Corrected Calcium
- •Ionized Calcium
- •Parathyroid Hormone Assays
- •First Generation Assays
- •Serum Phosphate
- •25-Hydroxyvitamin D (Vitamin D)
- •24-Hour Urine Calcium
- •Biochemical Stone Risk Analysis
- •1,25-Dihydroxy Vitamin D (Calcitriol)
- •Secondary Hyperparathyroidism
- •Medication Effects
- •Tertiary Hyperparathyroidism
- •Familial Hypocalciuric Hypercalcemia
- •Autoimmune Hypocalciuric Hypercalcemia
- •Pseudohypoparathyroidism
- •Imaging Evaluation
- •Plain Radiography
- •Dual-Energy X-ray Absorptiometry
- •Vertebral Fracture Assessment by DEXA
- •Trabecular Bone Score by DEXA
- •High-Resolution Peripheral Quantitative CT
- •Gland Localization
- •Parathyroid Ultrasound
- •SPECT-CT
- •4D Neck CT
- •Magnetic Resonance Imaging
- •Conclusions
- •References
- •Introduction
- •Etiology
- •Epidemiology
- •Pathophysiology
- •Androgen Production by Endocrine Glands
- •Clinical Evaluation
- •Laboratory Evaluation
- •Imaging Evaluation
- •Conclusion
- •References
- •Introduction
- •Etiology
- •Epidemiology
- •Pathophysiology
- •Pituitary Corticotroph Adenomas: Cushing’s Disease
- •Ectopic ACTH Syndrome
- •Unilateral Adrenal Adenoma
- •Adrenocortical Carcinoma
- •Bilateral Adrenal Nodular Disease
- •Clinical Evaluation
- •Musculoskeletal
- •Metabolic
- •Cardiovascular
- •Reproductive
- •Immune
- •Psychiatric
- •Laboratory Evaluation
- •Diagnosing Hypercortisolemia: 24-Hour Urine Free Cortisol
- •Diagnosing Hypercortisolemia: Low-Dose Dexamethasone Suppression Test
- •Diagnosing Hypercortisolemia: Late Night Salivary Free Cortisol
- •Determining ACTH Status
- •Imaging Evaluation
- •ACTH-Secreting Pituitary Adenomas
- •Ectopic ACTH Syndrome
- •ACTH-Independent Hypercortisolism
- •References
- •Introduction
- •Etiology/Physiology
- •Epidemiology
- •Insulinoma
- •Etiology/Pathophysiology
- •Epidemiology
- •Clinical Evaluation
- •Laboratory Evaluation
- •Gastrinoma
- •Etiology/Pathophysiology
- •Epidemiology
- •Clinical Evaluation
- •Laboratory Evaluation
- •Somatostatinomas
- •Etiology/Pathophysiology
- •Epidemiology
- •Clinical Evaluation
- •Laboratory Evaluation
- •VIPoma
- •Etiology/Pathophysiology
- •Epidemiology
- •Clinical Evaluation
- •Laboratory Evaluation
- •Imaging Evaluation
- •Conclusion
- •References
- •Epidemiology
- •Clinical Evaluation
- •Laboratory Evaluation
- •Glucagonomas
- •Etiology/Pathophysiology
- •Introduction
- •Primary Aldosteronism
- •Adrenal Vein Sampling
- •Anatomy
- •Embryology
- •Right Adrenal Vein
- •Left Arenal Vein
- •AVS Procedure
- •ACTH Stimulation
- •Technique
- •Rapid Cortisol Assay
- •Sequential vs. Simultaneous AVS
- •C-Arm Cone-Beam CT
- •Complications
- •Conclusion
- •References
- •Introduction
- •Indications
- •Techniques
- •Anatomy
- •Approaches
- •Technical Considerations
- •Interpretation
- •Complications
- •Outcomes
- •Conclusion
- •References
- •Introduction
- •Imaging Evaluation
- •Indications
- •Contraindications
- •Technique
- •Anatomy
- •Procedure Technique
- •Challenges
- •Results Interpretation
- •Complications
- •Conclusions
- •References
- •Introduction
- •Indications
- •Contraindications
- •Technique
- •Anatomy
- •Anatomical Variations
- •Pathophysiology
- •Approach
- •Technical Considerations
- •Complications
- •Conclusion
- •References
- •Introduction
- •Indications
- •Insulinomas
- •Gastrinomas
- •Nesidioblastosis
- •Other Indications
- •Contraindications
- •Technique
- •Anatomy
- •Procedure Technique
- •Outcomes
- •Complications
- •Conclusions
- •References
- •Hyperaldosteronism
- •Surgical/Pharmacological Therapy
- •Nuclear Medicine
- •Hyperparathyroidism
- •Primary Hyperparathyroidism: Surgical/Pharmacological Therapy
- •Secondary Hyperparathyroidism: Surgical/Pharmacological Therapy
- •Tertiary Hyperparathyroidism: Surgical/Pharmacological Therapy
- •Nuclear Medicine
- •Hyperandrogenism
- •Pharmacological Therapy
- •Nuclear Medicine
- •Pancreatic Endocrine Tumors
- •Surgical/Pharmacological Therapy
- •Nuclear Medicine
- •Hypercortisolism
- •Surgical/Pharmacological Therapy
- •Nuclear Medicine
- •References
- •Introduction
- •Preoperative Optimization
- •Adrenalectomy
- •Surgical Approach
- •Open Adrenalectomy
- •Laparoscopic Adrenalectomy
- •Transperitoneal (Transabdominal) Adrenalectomy
- •Retroperitoneal Adrenalectomy
- •Robotic Adrenalectomy
- •Partial Adrenalectomy
- •Complications
- •Postoperative Care
- •References
- •Preoperative Planning
- •Imaging
- •Ultrasound Evaluation
- •Nuclear Medicine Imaging Techniques
- •Dynamic Computed Tomography
- •Preoperative Medical Optimization
- •Indications
- •Contraindications
- •Surgical Interventions
- •Bilateral Cervical Exploration
- •Minimally Invasive Techniques
- •Autotransplantation
- •Complications
- •Postoperative Care
- •References
- •Introduction
- •Surgical Technique
- •Approach
- •Tumor Resection
- •Skull Base/Sellar Repair
- •Surgical Challenges
- •Postoperative Care
- •Conclusion
- •References
- •Introduction
- •Functional PNET
- •Insulinoma
- •Gastrinoma
- •Glucagonoma
- •VIPoma
- •Somatostatinoma
- •Nonfunctional PNET
- •Hereditary Syndromes
- •MEN-1
- •Von Hippel-Lindau Syndrome
- •Preoperative Workup
- •Operative Approaches
- •Curative Intent
- •Pancreatic Resections
- •Pancreaticoduodenectomy
- •Distal Pancreatectomy
- •Total Pancreatectomy
- •Enucleation
- •Transduodenal Approach
- •Nonlocalized Lesions
- •Other Operative Considerations
- •Cholecystectomy
- •Perioperative Somatostatin Analogues
- •Postoperative Care
- •Postoperative Complications
- •Pancreatic Fistula
- •Conclusion
- •References
- •Introduction
- •Adrenal Vein Sampling
- •Ablation
- •Patient Preparation
- •Procedure
- •Follow-Up
- •Outcomes
- •Embolization
- •Patient Preparation
- •Procedure
- •Follow-Up
- •Outcomes
- •Conclusion
- •References
- •Preprocedural Evaluation
- •Contraindications:
- •Preparation Before Thermal Ablation
- •Equipment Preparation
- •Patient Preparation
- •Thermal Ablation Procedure
- •Patient Position
- •Ultrasound Evaluation Before Ablation
- •Local Anesthesia
- •Liquid Isolation
- •Thermal Ablation
- •Percutaneous Parathyroid Injection
- •Indications
- •Contraindications
- •Preparation Before Treatment
- •Procedure
- •Treatment Strategy
- •References
- •Workups
- •Serum Thyroid Stimulation Hormone (TSH)
- •Thyroid Sonography
- •Bethesda System
- •Treatment
- •Benign Lesion
- •Malignant Lesion
- •Thyroid Radiofrequency Ablation
- •Indications
- •Indications
- •Contraindications
- •Anatomy
- •The Thyroid Gland
- •Vessels
- •Muscles
- •Nerves
- •Procedure
- •Preprocedural Workup
- •The Procedure
- •Results
- •Nonfunctioning Thyroid Nodules
- •Autonomously Functioning Thyroid Nodules
- •Marginal Regrowth
- •Complications
- •Pain
- •Voice Change
- •Hemorrhage
- •Hypothyroidism
- •Rupture
- •Tracheal Injury
- •Esophageal Injury
- •References
- •Introduction
- •Goiter Embolization
- •Summary
- •References
- •Introduction
- •Transarterial Embolization (TAE or “Bland” Embolization)
- •Basic Principles
- •Technique
- •Gelatin Sponge
- •Polyvinyl Alcohol Particles (PVA)
- •Microspheres
- •n-Butyl Cyanoacrylate
- •Transarterial Chemoembolization (TACE)
- •Conventional TACE
- •Drug-Eluting Beads TACE
- •Outcomes
- •TAE vs. TACE
- •Selective Internal Radiation Therapy (SIRT)
- •Technique
- •Outcomes
- •Percutaneous Ablation
- •Summary
- •References
- •Introduction
- •Pediatric Hypertension
- •Pathophysiology
- •Pediatric Fibromuscular Dysplasia
- •Pediatric Renal Vein Sampling
- •Preprocedural Preparation
- •Procedure Technique
- •Summary
- •References
- •Index

12 Surgical Treatment ofPrimary Aldosteronism
175
Transperitoneal (Transabdominal) Adrenalectomy
The laparoscopic transperitoneal adrenalectomy is most commonly performed via a
lateral approach [27] though some surgeons perform an anterior approach, especially in cases of other types of adrenal pathology where bilateral adrenalectomy is
indicated [28, 29]. One advantage of the lateral position is that gravity allows the
viscera to retract away from the surgical eld. We prefer the lateral approach.
We prefer to use a beanbag for positioning which is placed on the operating table
during room preparation. Draw sheets both below and on top of the beanbag facilitate positioning. The patient is initially placed supine on the operating table and
general anesthesia is induced. Secure intravenous access should be assured. In most
cases, continuous blood pressure monitoring via arterial access and central venous
access is not needed, though may be necessary in some patients due to specic
comorbidities. A Foley catheter should be placed. Sequential compression devices
are applied. The patient is moved if necessary, so that the space superior to the iliac
crest lies over the break point of the table. The patient is then turned into the full
lateral position with the appropriate side up. The table is exed fully to open the
space between the costal margin and iliac crest. The beanbag is then deated. The
arms are positioned in neutral positions away from the operative eld. The legs are
padded and secured in a neutral position.
Transabdominal Approach totheRight Adrenal Gland
The abdomen is entered either via a closed technique and the Veress needle or open
technique according to surgeon’s preference, and pneumoperitoneum is established
to 15mmHg. The rst port is usually positioned just medial to the anterior axillary
line. On the right side, usually a total of four ports are required as one will be needed
for liver retraction. The right lobe of the liver is retracted cephalad for exposure to
the retroperitoneum. Dissection is begun with opening of the posterior peritoneum
just inferior to the liver (Fig.12.1). In thinner patients, the inferior vena cava (IVC)
is usually visible just beneath the peritoneum. In larger patients, some dissection
may be required before the IVC becomes apparent. Dissection continues along the
border of the inferior vena cava to identify the right adrenal vein (Fig.12.2). The
right adrenal vein is a short, sizable vein often located cephalad to the inferior to the
edge of the liver. Early identication, dissection, and division of the right adrenal
vein are important to avoid surgical complication. The right adrenal vein is clipped
and then divided. The adrenal gland can then be dissected away from the IVC
(Fig.12.3). Dissection is carried along the adrenal gland with cautery or an energy
device, separating the gland from the retroperitoneal and perirenal adipose tissue.
During dissection, it is important not to directly grasp the adrenal gland. This will
cause the capsule to rupture resulting in copious bleeding that is difcult to control.
Disruption of the tumor may cause seeding of the surrounding space and diffuse

176
Fig. 12.1 Early view
during transabdominal
right adrenalectomy. The
arrow points to the adrenal
gland. The liver is retracted
cephalad. Dotted lines
indicate the inferior
vena cava
Fig. 12.2 Transabdominal
right adrenalectomy. The
short adrenal vein has been
exposed (arrow)
L. Kim and J. C. Mira
regrowth of tumor. Usually, the adrenal arterial supply is well controlled with cautery alone, but occasionally, larger vessels may require a clip or an energy device.
The superior pole of the kidney will become visible and the pararenal fat is taken
along with the adrenal. Care should be taken when dividing the pararenal fat because
the irregular shape of the adrenal gland may cause the surgeon to inadvertently
leave behind an adrenal limb. Once separated from the retroperitoneum, the adrenal
gland is placed in a laparoscopic collection bag and removed. We prefer a strong
bag that can tolerate substantial pressure since inadvertent spill of adrenal contents
during extraction can be disastrous. The extraction site is closed at the level of the
fascia to decrease the risk of incisional hernia. No drains are necessary.

12 Surgical Treatment ofPrimary Aldosteronism
Fig. 12.3 Transabdominal
right adrenalectomy. The
adrenal gland is being
mobilized away from the
inferior vena cava. The
white arrow points to the
edge of the adrenal gland.
The black arrow points to
the clipped stump of the
adrenal vein
Fig. 12.4 Transabdominal
left adrenalectomy. The
spleen and pancreas
complex have been
mobilized anteriorly to
expose the left adrenal
gland (dotted ellipse)
177
Transabdominal Approach totheLeft Adrenal Gland
The patient is placed in the left lateral decubitus position and the abdomen is entered
as described above. Usually, a total of three ports are adequate on the left (a camera
port and two working ports). The splenic exure of the colon is mobilized if necessary to expose the retroperitoneum. Gravity assists on medial retraction of the
splenic exure. The splenorenal and splenophrenic ligaments are divided, and the
peritoneum at the inferior edge of the pancreas is incised to allow for medialization
of the spleen and tail of the pancreas. Care is taken to avoid inadvertent pancreatic
injury. It is critical that the kidney is left undisturbed and the spleen/pancreas complex is mobilized as a unit. This will be an avascular plane that opens with gentle
traction and blunt dissection. Gravity will aid in the anterior retraction of the spleen.
The left adrenal gland may be visible in thin patients (Fig.12.4). Gerota’s fascia is

178
L. Kim and J. C. Mira
opened to expose the adrenal gland. Dissection is carried on the inferior border of
the adrenal gland to identify the left adrenal vein as it drains into the left renal vein.
The left adrenal vein is then identied, clipped, and divided (Fig.12.5). The inferior
phrenic vein may sometimes be seen as it joins the adrenal vein and may be preserved or transected, as necessary. Dissection is carried along the inferior border of
the left adrenal gland. Renal vessels will be nearby, and appropriate caution should
be taken to avoid their injury. Dissection is carried along the adrenal gland with
cautery separating the gland from the retroperitoneal and perirenal adipose tissue.
The superior pole of the kidney will become visible (Fig.12.6). The adrenal gland
is placed in a laparoscopic collection bag and the incisions closed as described above.
Fig. 12.5 Transabdominal
left adrenalectomy. The
adrenal vein has been
clipped but not yet divided.
The left renal vein is
outlined by the dotted lines
Fig. 12.6 Transabdominal
left adrenalectomy. The
adrenal gland has been
almost completely
dissected free. The kidney
(long arrow) and renal
artery branches (short
arrows) are seen

12 Surgical Treatment ofPrimary Aldosteronism
179
Retroperitoneal Adrenalectomy
Retroperitoneoscopic adrenalectomy was rst described in 1995 by MK Walz [30].
This approach may be favored in patients with prior abdominal surgeries and is
feasible in the obese [31]. Patients may be positioned in the lateral or prone genuect position. A large series by Walz of over 500 retroperitoneoscopic adrenalectomies showed excellent outcomes with zero mortality and 1.3% risk of major
complications [32]. Several groups have compared laparoscopic transabdominal
versus retroperitoneal adrenalectomies [33–35]. While some have favored retroperitoneal adrenalectomies for decreased operative times, blood loss, and hospital
length of stay, others have found no signicant difference, particularly in terms of
complication rates [33–35]. The Society of American Gastrointestinal and
Endoscopic Surgeons recommends that surgeons need to perform the approach they
are more familiar with and provide the best outcomes in their practice [36].
The patient is placed in the prone genuect position with all pressure points
padded. A 1.5–2cm incision is made at the tip of the 12th rib, and dissection is
carried bluntly to the retroperitoneal space. The initial working space is opened
with blunt dissection with the surgeon’s nger. Lateral and medial to this incision
are two laparoscopic working trocars placed using nger guidance. A sealing balloon or another trocar is placed in the initial incision, and the retroperitoneum is
insufated to 20mmHg to create a working space. The space is further developed
using blunt dissection over the superior pole of the right kidney retracting the
kidney caudally and laterally. The inferior aspect of the adrenal gland is identied and completely dissected off the superior pole of the kidney and retracted
cephalad (Fig.12.7). If operating on the right side, the adrenal vein is identied
at its insertion to the IVC medially and ventrally. If operating on the left side, the
renal vein may be identied and the adrenal vein is recognized as it enters the
Fig. 12.7 Posterior
retroperitoneal left
adrenalectomy. Early view
of the left adrenal gland
(arrow)

180
Fig. 12.8 Posterior
retroperitoneal left
adrenalectomy. The
grasper holds the adrenal
vein. A left inferior phrenic
vein can be seen joining
the left adrenal vein
(arrow)
L. Kim and J. C. Mira
renal vein. On the left, the inferior phrenic vein is often seen as it enters the adrenal vein (Fig.12.8). The adrenal vein is dissected circumferentially, clipped, and
divided. The adrenal gland is dissected off its retroperitoneal attachments superiorly and laterally using cautery or an energy device. The gland is removed in a
collection bag.
Robotic Adrenalectomy
Robotic surgery has become increasingly common in elective procedures.
Adrenalectomy is often performed with robotic assistance, either via the transabdominal or retroperitoneal approach. There is still debate on the benets of robotic
surgery over laparoscopy in adrenal surgery. Overall, there appears to be no difference in overall complications, with some studies favoring decreased blood loss and
length of stay for robotic surgery while increasing costs [37, 38]. We prefer to use
the robot for the transperitoneal approach because of improved visualization, dexterity, and ability to handle difcult situations such as a vascular injury. However,
we agree that the cost is higher and improved patient outcomes have not been clearly
shown. We do not use a non-robotic accessory port because of the limited working
space, though many surgeons do use an accessory port. With the posterior approach,
the available space between ports is very limited. For that reason, the use of a robot
may be difcult or impossible. Certainly, older robotic systems are particularly
problematic because of bulk. Newer, single-port systems might prove especially
useful for the posterior retroperitoneal approach. For now, we prefer not to use the
robot for the posterior approach (Fig.12.9).

12 Surgical Treatment ofPrimary Aldosteronism
Fig. 12.9 Typical
aldosteronoma showing the
classic golden-yellow color
of a cortical adenoma. The
specimen has been inked
181
Partial Adrenalectomy
An adrenal sparing approach has been suggested in patients with unilateral APAs
detected on imaging studies. Proponents of this approach note decreased risk of
adrenal insufciency with comparable cure rates and no increase in complications
[39, 40]. However, results are mixed. Other groups have shown increased rates of
persistent aldosteronism after partial adrenalectomy [41–43]. These groups demonstrate two ndings: (1) sectioned specimens show hyperplastic nodules at resection
margin adjacent to targeted adenoma and (2) nodules detected on imaging studies
are not always APAs, even with ipsilateral AVS lateralization, likely secondary to
the former. While data has shown improvement in subclinical transient hypocortisolism with partial adrenalectomy when compared to total adrenalectomy (11.5%
vs 25%, p< 0.001), rates of clinically signicant adrenal insufciency requiring
supplementation are equivalent (2.6% vs 1.9%, p=0.489), with no patients developing persistent hypocortisolism in either group [39]. Present guidelines recommend against partial adrenalectomy in PA given the risk of persistent
hyperaldosteronism without signicant benet over total adrenalectomy [3].
Complications
Laparoscopic adrenalectomy is a safe procedure with a 30-day mortality of <1%
and morbidity of 6.8–14.4% [32, 44, 45]. A granular data with regard to the complication grade and specic type of complications are generally lacking. Surgical morbidity after laparoscopic adrenalectomy can be classied in common complication
categories as in other types of abdominal procedures: bleeding, injury to adjacent

182
L. Kim and J. C. Mira
structures, conversion to open (for minimally invasive approaches), thromboembolic events, infections, cardiac events, pulmonary complications, complications
related to anesthesia and positioning, and nerve injuries, among others. Medical
complications related to adrenalectomy specic to primary aldosteronism may also
be observed: clinically signicant hyperkalemia and adrenal insufciency requiring
medical treatment.
Bleeding complications occur <4% in laparoscopic adrenalectomy [46, 47].
Careful dissection along the IVC and left renal veins must be undertaken with careful liver and splenic retraction to minimize events of major hemorrhage from vascular or parenchymal injury. In fact, while rates of conversion from laparoscopy to
laparotomy are <5%, open conversion is most associated with bleeding, less commonly due to extensive adhesive disease, visceral injury, and suspicion of malignancy [45, 47, 48]. Others have noted higher rates of bleeding in the right-sided
procedures while injury to adjacent organs was higher on the left side [47]. Failure
to respect the short right adrenal vein and careless dissection along the IVC on the
right or the inferior pancreatic border on the left can account for major bleeding
complication. Rates of pulmonary complications, postoperative infections, thromboembolic events, and cardiac events approach 1% or less each [44]. Drains are not
placed at the time of adrenalectomy but may be warranted in the event that a pancreatic injury is suspected as this facilitates a control of the pancreatic stula.
Following adrenalectomy, hyperkalemia has been observed in up to 6.3% of
patients secondary to contralateral suppression of aldosterone secretion with about
one third of these patients requiring mineralocorticoid replacement therapy [49].
Adrenal insufciency requiring steroid supplementation may occur in up to 2.6% of
patients [39].
Postoperative Care
Following adrenalectomy, electrolytes should be monitored to observe for development of hyperkalemia [3]. To minimize undesired hyperkalemia, potassium supplements and mineralocorticoid receptor antagonists should be stopped, balanced
crystalloid solutions without added potassium should be used for intravenous uid
therapy, and a low-potassium and high-sodium diet is recommended [50]. If hyperkalemia does not resolve spontaneously, mineralocorticoid replacement is necessary and continued outpatient monitoring is warranted [50]. Serum aldosterone
concentration and renin activity should be measured after surgery to ensure normalization of the aldosterone/renin ratio as evidence of biochemical response [3].
Finally, antihypertensives should be held and stopped if appropriate, keeping in
mind that it may require up to 3 months for hypertension to resolve after surgery
[51]. Patients should be reassessed annually with measurement of blood pressure
and serum potassium levels [10].

12 Surgical Treatment ofPrimary Aldosteronism
183
References
1. Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, etal. Prevalence and clini-
cal manifestations of primary Aldosteronism encountered in primary care practice. J Am Coll
Cardiol. 2017;69(14):1811–20.
2. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P.Hyperaldosteronism
among black and white subjects with resistant hypertension. Hypertension. 2002;40(6):892–6.
3. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, etal. The management
of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–916.
4. Farrugia FA, Zavras N, Martikos G, Tzanetis P, Charalampopoulos A, Misiakos EP, et al.
A short review of primary aldosteronism in a question and answer fashion. Endocr Regul.
2018;52(1):27–40.
5. Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, etal. Long-term
cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol
Metab. 2013;98(12):4826–33.
6. Sywak M, Pasieka JL.Long-term follow-up and cost benet of adrenalectomy in patients with
primary hyperaldosteronism. Br J Surg. 2002;89(12):1587–93.
7. Sukor N, Kogovsek C, Gordon RD, Robson D, Stowasser M.Improved quality of life, blood
pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary
aldosteronism. J Clin Endocrinol Metab. 2010;95(3):1360–4.
8. Young WF Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspec-
tives. J Intern Med. 2019;285(2):126–48.
9. Meng X, Ma WJ, Jiang XJ, Lu PP, Zhang Y, Fan P, etal. Long-term blood pressure outcomes
of patients with adrenal venous sampling-proven unilateral primary aldosteronism. J Hum
Hypertens. 2020;34(6):440–7.
10. Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, etal. Outcomes
after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes
Endocrinol. 2017;5(9):689–99.
11. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, etal. Renal damage in pri-
mary aldosteronism: results of the PAPY study. Hypertension. 2006;48(2):232–8.
12. Mulatero P, Sechi LA, Williams TA, Lenders JWM, Reincke M, Satoh F, etal. Subtype diag-
nosis, treatment, complications and outcomes of primary aldosteronism and future direction of
research: a position statement and consensus of the Working Group on Endocrine Hypertension
of the European Society of Hypertension. J Hypertens. 2020;38(10):1929–36.
13. Velema M, Dekkers T, Hermus A, Timmers H, Lenders J, Groenewoud H, etal. Quality of life
in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical
treatment. J Clin Endocrinol Metab. 2018;103(1):16–24.
14. Gershuni VM, Ermer JP, Kelz RR, Roses RE, Cohen DL, Trerotola SO, etal. Clinical pre-
sentation and surgical outcomes in primary aldosteronism differ by race. J Surg Oncol.
2020;121(3):456–64.
15. Burrello J, Burrello A, Stowasser M, Nishikawa T, Quinkler M, Prejbisz A, etal. The primary
aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism. Ann Surg. 2020;272(6):1125–32.
16. Yang Y, Williams TA, Song Y, Yang S, He W, Wang K, etal. Nomogram-based preoperative
score for predicting clinical outcome in unilateral primary aldosteronism. J Clin Endocrinol
Metab. 2020;105(12):dgaa634.
17. Zarnegar R, Young WF Jr, Lee J, Sweet MP, Kebebew E, Farley DR, etal. The aldosteronoma
resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg. 2008;247(3):511–8.

184
18. Harris DA, Wheeler MH.In: Linos D, Van Heerden JA, editors. History of adrenal surgery.
Berlin/New York: Springer; 2005.
19. Papadakis M, Manios A, Schoretsanitis G, Trompoukis C.Landmarks in the history of adrenal
surgery. Hormones (Athens). 2016;15(1):136–41.
20. Gagner M, Lacroix A, Bolte E.Laparoscopic adrenalectomy in Cushing’s syndrome and pheo-
chromocytoma. N Engl J Med. 1992;327(14):1033.
21. Thompson GB, Grant CS, van Heerden JA, Schlinkert RT, Young WF Jr, Farley DR, etal.
Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients.
Surgery. 1997;122(6):1132–6.
22. Shen WT, Lim RC, Siperstein AE, Clark OH, Schecter WP, Hunt TK, et al. Laparoscopic
vs open adrenalectomy for the treatment of primary hyperaldosteronism. Arch Surg.
1999;134(6):628–31; discussion 31–2.
23. Dickson PV, Kim L, Yen TWF, Yang A, Grubbs EG, Patel D, etal. Evaluation, staging, and
surgical management for adrenocortical carcinoma: an update from the SSO Endocrine and
Head and Neck Disease Site Working Group. Ann Surg Oncol. 2018;25(12):3460–8.
24. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, etal. Management of
adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in
collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol.
2016;175(2):G1–G34.
25. Seccia TM, Fassina A, Nussdorfer GG, Pessina AC, Rossi GP.Aldosterone-producing adre-
nocortical carcinoma: an unusual cause of Conn’s syndrome with an ominous clinical course.
Endocr Relat Cancer. 2005;12(1):149–59.
26. Proye CA, Huart JY, Cuvillier XD, Assez NM, Gambardella B, Carnaille BM.Safety of the
posterior approach in adrenal surgery: experience in 105 cases. Surgery. 1993;114(6):1126–31.
27. Raffaelli M, De Crea C, Bellantone R.Laparoscopic adrenalectomy. Gland Surg. 2019;8(Suppl
1):S41–52.
28. Balla A, Ortenzi M, Palmieri L, Corallino D, Meoli F, Ursi P, etal. Laparoscopic bilateral ante-
rior transperitoneal adrenalectomy: 24 years experience. Surg Endosc. 2019;33(11):3718–24.
29. Paganini AM, Balla A, Guerrieri M, Lezoche G, Campagnacci R, D’Ambrosio G, et al.
Laparoscopic transperitoneal anterior adrenalectomy in pheochromocytoma: experience in 62
patients. Surg Endosc. 2014;28(9):2683–9.
30. Walz MK, Peitgen K, Krause U, Eigler FW. [Dorsal retroperitoneoscopic adrenalectomy–a
new surgical technique]. Zentralbl Chir. 1995;120(1):53–8.
31. Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, etal. Posterior
retroperitoneoscopic adrenalectomy: a contemporary American experience. J Am Coll Surg.
2011;212(4):659–65; discussion 65–7.
32. Walz MK, Alesina PF, Wenger FA, Deligiannis A, Szuczik E, Petersenn S, et al. Posterior
retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients. Surgery.
2006;140(6):943–8; discussion 8-50.
33. Chai YJ, Kwon H, Yu HW, Kim SJ, Choi JY, Lee KE, etal. Systematic review of surgical
approaches for adrenal tumors: lateral transperitoneal versus posterior retroperitoneal and
laparoscopic versus robotic adrenalectomy. Int J Endocrinol. 2014;2014:918346.
34. Nigri G, Rosman AS, Petrucciani N, Fancellu A, Pisano M, Zorcolo L, etal. Meta-analysis
of trials comparing laparoscopic transperitoneal and retroperitoneal adrenalectomy. Surgery.
2013;153(1):111–9.
35. Conzo G, Tartaglia E, Gambardella C, Esposito D, Sciascia V, Mauriello C, etal. Minimally
invasive approach for adrenal lesions: systematic review of laparoscopic versus retroperitoneoscopic adrenalectomy and assessment of risk factors for complications. Int J Surg.
2016;28(Suppl 1):S118–23.
36. Stefanidis D, Goldfarb M, Kercher KW, Hope WW, Richardson W, Fanelli RD, et al.
SAGES guidelines for minimally invasive treatment of adrenal pathology. Surg Endosc.
2013;27(11):3960–80.
L. Kim and J. C. Mira
Соседние файлы в папке Библиотека им академика М.И. Перельмана
